Inventor · disambiguated record
Kazuyuki Kuramoto
Also filed as: KURAMOTO KAZUYUKI
6 granted patents·8 pending applications·30 citations·filing 2008–2025
74Inventor score
Top patents by PatentIndex Score
14 records- 0194US10556906B2Quinazoline compoundASTELLAS PHARMA INC·Filed 2019·Granted Feb 11, 2020·29 cites·12 claims
- 0267US2025340561A1Quinazoline compound for inducing degradation of g12d mutant kras proteinASTELLAS PHARMA INC·Filed 2025·Application pending·0 cites
- 0366US9428501B2Bicyclic nitrogen-containing aromatic heterocyclic amide compoundASTELLAS PHARMA INC·Filed 2014·Granted Aug 30, 2016·1 cites·20 claims
- 0464US12384794B2Quinazoline compound for inducing degradation of G12D mutant KRAS proteinASTELLAS PHARMA INC·Filed 2022·Granted Aug 12, 2025·0 cites·37 claims
- 0563US2025145631A1Heterocyclic compound acting on g12d mutant kras proteinASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 0662US10774082B2Quinazoline compoundASTELLAS PHARMA INC·Filed 2019·Granted Sep 15, 2020·0 cites·14 claims
- 0762US2025388569A1Heterocyclic compound for inhibiting and/or inducing degradation of kras proteinASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 0860US2025206751A1Heterocyclic compound for inducing degradation of g12d mutant kras proteinASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 0956US8815920B2Substituted amide compoundASTELLAS PHARMA INC·Filed 2013·Granted Aug 26, 2014·0 cites·5 claims
- 1055US2024150366A14-aminoquinazoline compoundASTELLAS PHARMA INC·Filed 2022·Application pending·0 cites
- 1152US2025084092A1Annulated pyridazine compoundNICO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1245US2010267775A1Oxadiazolidinedione compoundNEGORO KENJI·Filed 2008·Application pending·0 cites
- 1338US8669246B2Substituted amide compoundKAWAMINAMI EIJI·Filed 2010·Granted Mar 11, 2014·0 cites·26 claims
- 1434US2012035196A1Carboxylic acid compoundNEGORO KENJI·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kazuyuki Kuramoto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →